Products Category
Antibody-drug Conjugate/ADC Related
Trk Receptor
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
|
Product name : Linsitinib(OSI906)
Item : CR1207
CAS : 867160-71-2
 |
| Details: |
Description of:Linsitinib(OSI906)
Linsitinib(OSI906) is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR). OSI-906 is currently in a Phase III clinical trial in adrenocortical carcinoma (ACC) and in a Phase I/II clinical trial in ovarian cancer. Theoretical analysis:Linsitinib(OSI906) M.Wt:421.49 Formula: C26H23N5O Solubility: Unknown Purity: >98% Storage: at -20℃ 2 years CAS No: 867160-71-2 Availability and price:Linsitinib(OSI906) Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
| Related Products : |
|
|
|
|
||||||||
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian